Thienopyrimidines useful as Aurora kinase inhibitors
    5.
    发明申请
    Thienopyrimidines useful as Aurora kinase inhibitors 失效
    噻吩并嘧啶可用作极光激酶抑制剂

    公开(公告)号:US20060035908A1

    公开(公告)日:2006-02-16

    申请号:US11182215

    申请日:2005-07-15

    IPC分类号: A61K31/519 C07D498/02

    CPC分类号: C07D495/04

    摘要: The present invention provides compounds having the formula: wherein R1, R2, X1, X2, L1, L2, Y and Z are as defined in classes and subclasess herein, and pharmaceutical compositions thereof, as described generally and in subclasses herein, which compounds are useful as inhibitors of protein kinase (e.g., Aurora), and thus are useful, for example, for the treatment of Aurora mediated diseases.

    摘要翻译: 本发明提供具有下式的化合物:其中R 1,R 2,X 1,X 2, L 1,L 2,Y和Z如本文中的类别和亚临界所定义,以及其在本文中通常和在本文中描述的药物组合物,该化合物可用作 蛋白激酶抑制剂(例如Aurora),因此可用于治疗Aurora介导的疾病。

    ENTERPRISE COMPUTING PLATFORM
    6.
    发明申请
    ENTERPRISE COMPUTING PLATFORM 有权
    企业计算平台

    公开(公告)号:US20130047135A1

    公开(公告)日:2013-02-21

    申请号:US13306903

    申请日:2011-11-29

    IPC分类号: G06F9/44

    CPC分类号: G06F8/30

    摘要: Various technologies related to an enterprise computing platform are presented. A new level of software development can be achieved by avoiding the coding process. An enterprise computing platform having a variety of frameworks can be configured to operate in a variety of business domains. Features such as parallel computing, distributed computing, logical documents, document transformation, space visualization, data security, and others can be accomplished via configuration rather than coding. Considerable efficiency improvements in the software development process can be realized.

    摘要翻译: 介绍了与企业计算平台相关的各种技术。 通过避免编码过程,可以实现新的软件开发水平。 具有各种框架的企业计算平台可以配置为在各种业务领域中运行。 可以通过配置而不是编码来实现并行计算,分布式计算,逻辑文档,文档转换,空间可视化,数据安全等功能。 可以实现软件开发过程中效率的提高。

    Glycopolymers and free radical polymerization methods
    9.
    发明授权
    Glycopolymers and free radical polymerization methods 失效
    甘油聚合物和自由基聚合方法

    公开(公告)号:US07244830B2

    公开(公告)日:2007-07-17

    申请号:US10451011

    申请日:2002-01-14

    IPC分类号: C07H5/06 C07H1/00

    CPC分类号: C08B37/00 C08B37/0063

    摘要: A glycopolymer composition is provided comprising glycopolymer molecules having a polymer backbone; a first pendent unit comprising a linking group connected to said polymer backbone and a saccharide moiety connected to said linking group, optionally a second pendent unit; a phenyl ring at a first end of the polymer backbone; and a cyanoxyl group at the second end of the polymer backbone, useful as intermediates for making bioactive glycopolymers which bind to bioactive molecules, viruses, cells and substrates for protein separation, cell culture, ad drug delivery systems, as well as in targeting for treatment of wound healing and other pathological conditions.

    摘要翻译: 提供了包含具有聚合物主链的聚合物聚合物分子的糖聚合物组合物; 第一悬挂单元,其包含连接到所述聚合物主链的连接基团和连接到所述连接基团的糖部分,任选地是第二侧挂单元; 在聚合物骨架的第一端的苯环; 和在聚合物主链的第二端的氰氧基,其可用作生物活性糖聚合物的中间体,其结合用于蛋白质分离,细胞培养,药物递送系统的生物活性分子,病毒,细胞和底物,以及靶向治疗 的伤口愈合等病理状况。